EE200000384A - Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool - Google Patents

Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool

Info

Publication number
EE200000384A
EE200000384A EEP200000384A EEP200000384A EE200000384A EE 200000384 A EE200000384 A EE 200000384A EE P200000384 A EEP200000384 A EE P200000384A EE P200000384 A EEP200000384 A EE P200000384A EE 200000384 A EE200000384 A EE 200000384A
Authority
EE
Estonia
Prior art keywords
propoxyphenoxy
isopropylmethyl
amine
ethyl
phosphate salt
Prior art date
Application number
EEP200000384A
Other languages
English (en)
Estonian (et)
Inventor
Horvath Karol
Larsson Ulf
Sandberg Rune
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000384A publication Critical patent/EE200000384A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000384A 1997-12-22 1998-12-15 Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool EE200000384A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704835A SE9704835D0 (sv) 1997-12-22 1997-12-22 New compound
PCT/SE1998/002316 WO1999032431A1 (en) 1997-12-22 1998-12-15 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL-[2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE

Publications (1)

Publication Number Publication Date
EE200000384A true EE200000384A (et) 2001-12-17

Family

ID=20409538

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000384A EE200000384A (et) 1997-12-22 1998-12-15 Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool

Country Status (22)

Country Link
US (1) US6235792B1 (xx)
EP (1) EP1047663A1 (xx)
JP (1) JP2001526254A (xx)
KR (1) KR20010033407A (xx)
CN (1) CN1280559A (xx)
AR (1) AR017199A1 (xx)
AU (1) AU1989299A (xx)
BR (1) BR9814381A (xx)
CA (1) CA2314989A1 (xx)
EE (1) EE200000384A (xx)
HU (1) HUP0004428A3 (xx)
ID (1) ID26940A (xx)
IL (1) IL136829A0 (xx)
IS (1) IS5544A (xx)
NO (1) NO20003216D0 (xx)
PL (1) PL341525A1 (xx)
SE (1) SE9704835D0 (xx)
SK (1) SK8062000A3 (xx)
TR (1) TR200002012T2 (xx)
TW (1) TW455590B (xx)
WO (1) WO1999032431A1 (xx)
ZA (1) ZA9811237B (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
AR004691A1 (es) 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
HUP0004428A3 (en) 2002-04-29
NO20003216L (no) 2000-06-21
CA2314989A1 (en) 1999-07-01
WO1999032431A1 (en) 1999-07-01
HUP0004428A2 (hu) 2002-03-28
EP1047663A1 (en) 2000-11-02
SE9704835D0 (sv) 1997-12-22
IS5544A (is) 2000-06-21
ZA9811237B (en) 1999-07-19
KR20010033407A (ko) 2001-04-25
NO20003216D0 (no) 2000-06-21
TW455590B (en) 2001-09-21
JP2001526254A (ja) 2001-12-18
CN1280559A (zh) 2001-01-17
BR9814381A (pt) 2000-10-10
PL341525A1 (en) 2001-04-23
SK8062000A3 (en) 2001-02-12
AR017199A1 (es) 2001-08-22
TR200002012T2 (tr) 2000-10-23
IL136829A0 (en) 2001-06-14
US6235792B1 (en) 2001-05-22
AU1989299A (en) 1999-07-12
ID26940A (id) 2001-02-22

Similar Documents

Publication Publication Date Title
EE9900259A (et) Ühendi uus vorm
IS2027B (is) Ný spíróasabísýklísk heterósýklísk efnasambönd
DE69811892D1 (de) Kristalline form von omeprazol-natriumsalz
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
DE69812007T2 (de) Aliphatische Lösungen von Aminoalkyllithiumverbindungen
DK1028111T3 (da) Amidderivater eller salte heraf
PT1027332E (pt) Novas lactamas inibidoras de metaloproteases
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
PT958287E (pt) Inibidores de sulfamida-metaloprotease
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID24455A (id) Alat untuk penyatuan-amorf pipa-pipa
DK0928192T3 (da) Antimykotisk gel med høj frigivelse af aktivt stof
NO20000686L (no) Enantiomerer av 4-[[(cyanoimino)-[(1,2,2- trimetylpropyl)amino]metyl]amino]benzonitril
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
EE200000384A (et) Isopropüülmetüül-[2-(3-n-propoksüfenoksü)etüül]amiini uus fosfaatsool
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
EE9900455A (et) Uus menetlus
DE69811256D1 (de) Polymorphe modifikationen von dofetilid